Position in OCUL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$423,500
+$423,500 QoQ
Shares Held
50,000
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in OCUL
reported options exposure · as of Dec 31, 2025CallValue
$1,044,040
CallShares
86,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026NOMURA HOLDINGS INC holds $206,438,773 across 46 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
402,192 | $31,889,803 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
327,475 | $24,390,338 | |
| 3 | LGND |
Ligand Pharmaceuticals Inc
|
61,938 | $19,577,982 | |
| 4 | AUPH |
Aurinia Pharmaceuticals Inc.
|
978,602 | $16,606,875 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
417,932 | $15,216,904 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
29,198 | $14,503,522 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,320 | $8,929,092 | |
| 8 | ABUS |
Arbutus Biopharma Corp
|
1,637,081 | $7,857,988 |
All Filings in OCUL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $423,500 | 50,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,044,040 | 86,000 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $541,247 | 46,300 | Call | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||